|
511 |
Patient-Reported Outcome-Based Symptom Management Improves Quality of Life in Postoperative Gastroesophageal Cancer Patients: A Randomized Controlled Trial
Enthalten in Oncology Bd. 104, 2026, Nr. 2: 201-211. 11 S.
|
|
|
|
512 |
Impact of Social Vulnerability Index on Multiple Myeloma Mortality
Enthalten in Oncology Bd. 104, 2026, Nr. 2: 176-180. 5 S.
|
|
|
|
513 |
Determining the Cut-Off Value of the MASCC Score to Predict Mortality in Hospitalized Febrile Neutropenic Patients: A Decade-Long Single-Center Retrospective Cohort Study
Enthalten in Oncology Bd. 104, 2026, Nr. 2: 167-175. 9 S.
|
|
|
|
514 |
Antihistamines Improve the Survival of Lung Cancer: A 10-Year Cohort Study of Tertiary Hospital in Taiwan
Enthalten in Oncology Bd. 104, 2026, Nr. 2: 103-112. 10 S.
|
|
|
|
515 |
The Current Status of Tumor Markers as Biomarkers in the Era of Immunotherapy for Hepatocellular Carcinoma: Alpha-Fetoprotein Alone Is Not Sufficient
Enthalten in Oncology Bd. 104, 2026, Nr. 1: 79-91. 13 S.
|
|
|
|
516 |
Variations in Characteristics and Clinical Outcomes of Esophageal Squamous Cell Carcinoma among Asian American
Enthalten in Oncology Bd. 104, 2026, Nr. 1: 51-62. 12 S.
|
|
|
|
517 |
ISPAD Position Statement on Type 1 Diabetes in Schools
Enthalten in Hormone research in paediatrics Bd. 99, 2026, Nr. 1: 147-157. 11 S.
|
|
|
|
518 |
Variability in Body Mass Index during 2018–2021 for People with Type 1 Diabetes: Real World Data from the USA, Germany, and Australasia
Enthalten in Hormone research in paediatrics Bd. 99, 2026, Nr. 1: 138-146. 9 S.
|
|
|
|
519 |
Phase 2 Trial of Vosoritide Use in Patients with Hypochondroplasia: A Pharmacokinetic/Pharmacodynamic Analysis
Enthalten in Hormone research in paediatrics Bd. 99, 2026, Nr. 1: 131-137. 7 S.
|
|
|
|
520 |
Strategies for Equitable Recruitment to Engage Underrepresented Youth and Their Families into Clinical Research: Findings from the BEAD-T1D Pilot Study
Enthalten in Hormone research in paediatrics Bd. 99, 2026, Nr. 1: 122-130. 9 S.
|
|
Administration
